Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | Nilotinib | 0.31623 | uM | 10 | 5000.00 | 2314.91 | 5773.00 | 6664.50 | 0.8662 | 0.8203 |
| MDA-MB-231 | 0 | uM | 10 | 5000.00 | 2314.91 | 6686.00 | 6664.50 | 1.0032 | 1.0042 | |
| MDA-MB-231 | 0 | uM | 10 | 5000.00 | 2314.91 | 6643.00 | 6664.50 | 0.9968 | 0.9958 | |
| MDA-MB-231 | 0 | uM | 11 | 156.25 | 67.09 | 293.00 | 347.75 | 0.8426 | 0.8608 | |
| MDA-MB-231 | Omipalisib | 0.0033113 | uM | 11 | 156.25 | 67.09 | 328.00 | 347.75 | 0.9432 | 0.9513 |
| MDA-MB-231 | Nilotinib | 0.31623 | uM | 11 | 156.25 | 67.09 | 377.00 | 347.75 | 1.0841 | 1.0692 |
| MDA-MB-231 | Omipalisib | 0.1 | uM | 11 | 156.25 | 67.09 | 172.00 | 347.75 | 0.4946 | 0.4867 |
| MDA-MB-231 | Palbociclib | 10 | uM | 11 | 156.25 | 67.09 | 129.00 | 347.75 | 0.3710 | 0.3171 |
| MDA-MB-231 | 0 | uM | 11 | 156.25 | 67.09 | 416.00 | 347.75 | 1.1963 | 1.1568 | |
| MDA-MB-231 | Palbociclib | 19.9526 | uM | 11 | 156.25 | 67.09 | 152.00 | 347.75 | 0.4371 | 0.4113 |
| MDA-MB-231 | Palbociclib | 0.31623 | uM | 11 | 156.25 | 67.09 | 299.00 | 347.75 | 0.8598 | 0.8767 |
| MDA-MB-231 | Nilotinib | 0.031623 | uM | 11 | 156.25 | 67.09 | 541.00 | 347.75 | 1.5557 | 1.4092 |
| MDA-MB-231 | Palbociclib | 3.1623 | uM | 11 | 156.25 | 67.09 | 155.00 | 347.75 | 0.4457 | 0.4230 |
| MDA-MB-231 | Omipalisib | 10 | uM | 11 | 156.25 | 67.09 | 112.00 | 347.75 | 0.3221 | 0.2409 |
| MDA-MB-231 | Taxol | 0.00016596 | uM | 11 | 156.25 | 67.09 | 361.00 | 347.75 | 1.0381 | 1.0318 |
| MDA-MB-231 | Nilotinib | 10 | uM | 11 | 156.25 | 67.09 | 816.00 | 347.75 | 2.3465 | 1.8647 |
| MDA-MB-231 | Palbociclib | 1 | uM | 11 | 156.25 | 67.09 | 157.00 | 347.75 | 0.4515 | 0.4307 |
| MDA-MB-231 | Palbociclib | 0.1 | uM | 11 | 156.25 | 67.09 | 275.00 | 347.75 | 0.7908 | 0.8117 |
| MDA-MB-231 | Palbociclib | 0.0033113 | uM | 11 | 156.25 | 67.09 | 390.00 | 347.75 | 1.1215 | 1.0990 |
| MDA-MB-231 | Taxol | 0.001 | uM | 11 | 156.25 | 67.09 | 272.00 | 347.75 | 0.7822 | 0.8034 |
| MDA-MB-231 | Palbociclib | 0.01 | uM | 11 | 156.25 | 67.09 | 375.00 | 347.75 | 1.0784 | 1.0646 |
| MDA-MB-231 | Nilotinib | 1 | uM | 11 | 156.25 | 67.09 | 467.00 | 347.75 | 1.3429 | 1.2645 |
| MDA-MB-231 | Nilotinib | 19.9526 | uM | 11 | 156.25 | 67.09 | 487.00 | 347.75 | 1.4004 | 1.3049 |
| MDA-MB-231 | Taxol | 1 | uM | 11 | 156.25 | 67.09 | 84.00 | 347.75 | 0.2416 | 0.0993 |
| MDA-MB-231 | 0 | uM | 11 | 156.25 | 67.09 | 246.00 | 347.75 | 0.7074 | 0.7286 |